5-bromo-N-[[2-(2-cyclopropylideneethoxy)-4-methoxyphenyl]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
C19H19BrN4O2 — CID 156731617
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-bromo-N-[[2-(2-cyclopropylideneethoxy)-4-methoxyphenyl]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
5-bromo-N-[[2-(2-cyclopropylideneethoxy)-4-methoxyphenyl]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine (PubChem CID 156731617) has the molecular formula C19H19BrN4O2 and a molecular weight of 415.29 g/mol. Its IUPAC name is 5-bromo-N-[[2-(2-cyclopropylideneethoxy)-4-methoxyphenyl]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine.
Molecular Properties
| Compound Name | 5-bromo-N-[[2-(2-cyclopropylideneethoxy)-4-methoxyphenyl]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
|---|---|
| PubChem CID | 156731617 |
| Molecular Formula | C19H19BrN4O2 |
| Molecular Weight | 415.29 g/mol |
| Exact Mass | 414.07 |
| IUPAC Name | 5-bromo-N-[[2-(2-cyclopropylideneethoxy)-4-methoxyphenyl]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| SMILES | COc1ccc(CNc2ncnc3[nH]cc(Br)c23)c(OCC=C2CC2)c1 |
| InChI | InChI=1S/C19H19BrN4O2/c1-25-14-5-4-13(16(8-14)26-7-6-12-2-3-12)9-21-18-17-15(20)10-22-19(17)24-11-23-18/h4-6,8,10-11H,2-3,7,9H2,1H3,(H2,21,22,23,24) |
| InChIKey | VDLKNEUHIGZEHK-UHFFFAOYSA-N |
| XLogP | 4.44 |
| TPSA | 72.06 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 415.29 |
| LogP ≤ 5 | 4.44 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156731617 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.